Documento descargado de http://www.elsevier.es el 20/06/2016.

Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato.

Perinatol Reprod Hum. 2015;29(3):122-129

P erinatología
Y R EPRODUCCIÓN HUMANA
www.elsevier.es/rprh

REVISIÓN

Reemplazo estrogénico en pacientes con síndrome

de Turner

F. Pérez Bueno*, J.R. Aguilera Pérez y P. Garza Ríos

Coordinación de Peri-Posmenopausia, Instituto Nacional de Perinatología, México D.F., México

5HFLELGRHOGHDEULOGHDFHSWDGRHOGHDJRVWRGH

PALABRAS CLAVE Resumen (OVtQGURPHGH7XUQHU67HVXQWUDVWRUQRJHQpWLFRDVRFLDGRFRQDQRUPDOLGDGHVGHO

3XEHUWDG cromosoma X, que ocurre un 1 caso por cada 2,000 a 2,500 mujeres nacidas vivas. Se asocia
(VWUyJHQRV JHQHUDOPHQWHFRQWDOODEDMDGLVJHQHVLDJRQDGDO\QLYHOHVFLUFXODQWHVLQVXÀFLHQWHVGHHVWHURL-
3URJHVWiJHQRV GHVVH[XDOHVTXHFRQGXFHQDLQVXÀFLHQFLDRYiULFDHLQIHUWLOLGDG(OPDQHMRGHODWHUDSLDKRUPR-
Síndrome de Turner; QDOGHUHHPSOD]R7+5HQODDGROHVFHQWHHVD~QXQWHPDFRQWURYHUVLDO/DWHUDSLDFRQHVWUy-
7HUDSLDKRUPRQDO JHQRVHVWiGLVSRQLEOHHQGLYHUVDVIRUPXODFLRQHV\GLIHUHQWHVUHJtPHQHVTXHUHTXLHUHQHVWXGLRV
GHUHHPSOD]R GHODVGLIHUHQFLDVHQORVHIHFWRVVREUHODVDOXG\VHJXULGDG
(VWHDUWtFXORUHYLVDODOLWHUDWXUDPpGLFDVREUHWHUDSLDKRUPRQDOGHUHHPSOD]RHQSDFLHQWHVFRQ
676HUHDOL]yXQDE~VTXHGDHQODEDVHGHGDWRVGH3XE0HG\HQODVSULQFLSDOHVUHYLVWDVGHHQ-
GRFULQRORJtDFRQFHQWUDQGRORVDUWtFXORVSXEOLFDGRVGH67FRQHVSHFLDOpQIDVLVHQODOLWHUDWXUD
reciente.
3RUHOWLSRGHHVWXGLRVSXEOLFDGRVHOQ~PHURGHSDFLHQWHVLQYROXFUDGRVHOWLHPSRGHVHJXL-
PLHQWR\ODGLYHUVLGDGGHHVTXHPDVGHWUDWDPLHQWRXWLOL]DGRVIXHGLItFLOWHQHUXQDFRPSDUDFLyQ
REMHWLYDSRUORTXHFRQVLGHUDPRVLPSUHVFLQGLEOHODUHDOL]DFLyQGHHVWXGLRVSURVSHFWLYRVPXOWL-
FpQWULFRVTXHSHUPLWDQIRUPXODUJXtDVGHDWHQFLyQGHODVSDFLHQWHVFRQ67
‹,QVWLWXWR1DFLRQDOGH3HULQDWRORJtD,VLGUR(VSLQRVDGHORV5H\HV3XEOLFDGRSRU0DVVRQ'R\PD
0p[LFR6$(VWHHVXQDUWtFXOR2SHQ$FFHVVEDMRODOLFHQFLD&&%<1&1'KWWSFUHDWLYHFRPPRQV
RUJOLFHQVHVE\QFQG

KEYWORDS Estrogen replacement in women with Turner’s syndrome

3XEHUW\
(VWURJHQ Abstract 7KH7XUQHUV\QGURPH76LVDJHQHWLFGLVRUGHUDVVRFLDWHGZLWKDEQRUPDOLWLHVLQWKH
3URJHVWHURQH FKURPRVRPH;ZKLFKRFFXULQRXWRIWRIHPDOHOLYHELUWKV8VXDOO\LVDVVRFLDWHG
7XUQHU6\QGURPH ZLWKORZVL]HJRQDGGLJHQHVLVDQGLQVXIÀFLHQWFLUFXODWLQJOHYHOVRIVH[VWHURLGVOHDGLQJWRRYDU-
Hormone replacement LDQIDLOXUHDQGLQIHUWLOLW\7KHXVHRIWKHKRUPRQDOUHSODFHPHQWWKHUDS\+57LQWKHDGROHV-
WKHUDS\ FHQWVLVVWLOODFRQWURYHUVLDOWRSLF(VWURJHQWKHUDS\LVDYDLODEOHLQPDQ\IRUPXODWLRQVDQGGLIIHU-
HQWUHJLPHVUHTXLULQJVWXGLHVRIGLIIHUHQFHVLQWKHHIIHFWVRQKHDOWKDQGVDIHW\

* Autor para correspondencia.

Correo electrónico:ÁRUBSE#\DKRRFRPP[)3pUH]%XHQR
0187-5337/ © 2015 Instituto Nacional de Perinatología Isidro Espinosa de los Reyes. Publicado por Masson Doyma México S.A. Este es un artículo Open
Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Documento descargado de http://www.elsevier.es el 20/06/2016. Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato.

5HHPSOD]RHVWURJpQLFRHQSDFLHQWHVFRQVtQGURPHGH7XUQHU 

7KLVDUWLFOHUHYLHZVWKHOLWHUDWXUHRQ+57LQSDWLHQWVZLWK76$VHDUFKZDVFRQGXFWHGLQWKH
3XE0HGGDWDEDVHDQGWKHPDLQPDJD]LQHVRI(QGRFULQRORJ\FRQFHQWUDWLQJ76SXEOLVKHGDUWLFOHV
ZLWKVSHFLDOHPSKDVLVRQUHFHQWOLWHUDWXUH
%\WKHW\SHRISXEOLVKHGVWXGLHVWKHQXPEHURISDWLHQWVLQYROYHGWLPHWUDFNLQJDQGWKHGLYHU-
VLW\RIVFKHPHVRIWUHDWPHQWXVHGLWLVGLIÀFXOWWRKDYHDQREMHFWLYHFRPSDULVRQVRPXOWL-
FHQWHUSURVSHFWLYHVWXGLHVWKDWDOORZWRIRUPXODWHJXLGHOLQHVLVHVVHQWLDO
‹,QVWLWXWR1DFLRQDOGH3HULQDWRORJtD,VLGUR(VSLQRVDGHORV5H\HV3XEOLVKHGE\0DVVRQ'R\PD
0p[LFR6$7KLVLVDQRSHQDFFHVVDUWLFOHXQGHUWKH&&%<1&1'OLFHQVHKWWSFUHDWLYHFRPPRQV
RUJOLFHQVHVE\QFQG
'HÀQLFLyQGHVtQGURPHGH7XUQHU
El síndrome de Turner es un trastorno cromosómico que se
FDUDFWHUL]DSRUODSUHVHQFLDGHXQQ~PHURYDULDEOHGHFDP-
ELRVHQHOIHQRWLSR\HQORVyUJDQRVLQWHUQRVVLHQGRODGLV-
JHQHVLDJRQDGDO\ODWDOODEDMDORVKDOOD]JRVPiVWtSLFRV(O
síndrome es causado por la ausencia parcial o completa de
XQFURPRVRPD;HQDOPHQRVXQWHMLGRGHORUJDQLVPR1.
GHODVSDFLHQWHVDIHFWDGDVVRQGLDJQRVWLFDGDVSRUVXVFDUDF-
WHUtVWLFDVIHQRWtSLFDVHQODDGROHVFHQFLDHOSRUODEDMD
HVWDWXUDDGHPiVVHSXHGHQHQFRQWUDUQLYHOHVHOHYDGRVGH
)6+\DXVHQFLDGHFDUDFWHUtVWLFDVVH[XDOHVVHFXQGDULDV(Q
0p[LFRHOGLDJQyVWLFRVHVXHOHUHDOL]DHQSURPHGLRHQWUHORV
\DxRVGHHGDG3.
&XDQGRVHVRVSHFKDHOGLDJQyVWLFRGH67GHEHUHDOL]DUVH
XQFDULRWLSR&XDQGRUHDOL]DPRVHOHVWXGLRFURPRVyPLFR
FRQYHQFLRQDOHQFXOWLYRGHVDQJUHSHULIpULFDFHUFDGHO
Historia y terminología
(Q+HQU\+7XUQHUGHVFULELyHQVLHWHPXMHUHVXQFXD-
GURFDUDFWHUL]DGRSRUHVWDWXUDEDMDDXVHQFLDGHFDUDFWHUHV
VH[XDOHVIHPHQLQRVpterigium colli\cubitus valguspOFRQ-
VLGHUyTXHXQDDOWHUDFLyQKLSRÀVDULDHUDODFDXVDUHVSRQVD-
EOHGHODIDOWDGHIXQFLyQRYiULFDGHHVWDVSDFLHQWHV
3UHYLDPHQWH2WWR8OOULFKKDEtDGHVFULWRHOPLVPRFXDGUR
FOtQLFRHQ(Q)RUGHWDOFRPXQLFDURQODSpUGLGD
de uno de los cromosomas X en las pacientes con síndrome
de Turner.
Prevalencia
/DSUHYDOHQFLDGHVFULWDHQHOPXQGRHVGH;D;
UHFLpQQDFLGRYLYRVGHOVH[RIHPHQLQR&HUFDGHOD
GHORVFDVRVPXHVWUDQXQDPRQRVRPtD;;2WURVFDULR-
tipos que se encuentran en el ST son mosaicismos con otras
OtQHDVFHOXODUHVWDOHVFRPR;;R;<y;;</DV
DQRPDOtDVHVWUXFWXUDOHVGHOFURPRVRPD;VRQWDPELpQIUH-
FXHQWHVWDOHVFRPRLVRFURPRVRPDGHEUD]RVODUJRVGHOFUR-
mosoma X, deleciones, anillos o translocaciones.
3DFLHQWHVFRQFDULRWLSR;WLHQHQPiVFDUDFWHUtVWLFDV
clínicas que aquellos que tienen mosaicismo con una línea
celular normal; pero en los casos de mosaicismo, es impor-
WDQWHLQYHVWLJDUODSUHVHQFLDGHXQDOtQHDFHOXODUTXHWHQJD
HOFURPRVRPD<HOFXDOVHHQFXHQWUDHQDSUR[LPDGDPHQWH
HQHOGHORVFDVRV\DTXHFXDQGRHVWHFURPRVRPDHVWi
SUHVHQWHH[LVWHXQULHVJRLQFUHPHQWDGRGHGHGHVD-
UUROODUXQJRQDGREODVWRPD\GLVJHUPLQRPDHQODJOiQGXOD
GLVJHQpVLFDSRUORTXHVHUHFRPLHQGDXQDJRQDGHFWRPtD
SURÀOiFWLFD5.
$OJXQRVDXWRUHVFRQVLGHUDQTXHWRGRVORVIHWRVYLDEOHVVRQ
PRVDLFRV\TXHODLQDFWLYDFLyQGHOFURPRVRPD;IDOWDQWH
RFXUUHGHVSXpVGHODIHUWLOL]DFLyQ(QJHQHUDOHO67QRHV
IDPLOLDU\QRH[LVWHPD\RUULHVJRSDUDODVPXMHUHVTXH\D
2% de todas las concepciones presentan una monosomía X;
GHHOODVWHUPLQDQHQDERUWRVHVSRQWiQHRVJHQHUDOPHQ-
WHGXUDQWHHOSULPHUWULPHVWUHGHOHPEDUD]R2(Q0p[LFRVH
GHVFRQRFHODSUHYDOHQFLDH[DFWD(Q1RYLHPEUHGHOOD
$VRFLDFLyQGHO6tQGURPHGH7XUQHUGH0p[LFR$&FRQWDED
con 300 pacientes inscritos3.
'LDJQyVWLFR
(OGLDJQyVWLFRVHHVWDEOHFHSRUODVGLYHUVDVFDUDFWHUtVWLFDV
FOtQLFDVSXHGHVRVSHFKDUVHSUHQDWDOPHQWHSRUODSUHVHQFLD
GHKDOOD]JRVXOWUDVRQRJUiÀFRVHVSHFtÀFRVFRPRHGHPDIH-
WXYLHURQXQKLMRDERUWDGRRYLYRFRQHVWHVtQGURPHGHWH-
QHURWURKLMRFRQHOPLVPRSDGHFLPLHQWR
0RGLÀFDFLRQHVKRUPRQDOHV
/DVPRGLÀFDFLRQHVKRUPRQDOHVSUHVHQWHVHQHO67GHULYDQ
SULQFLSDOPHQWHGHODDOWHUDFLyQGHODIXQFLyQRYiULFD(O
SURFHVRGHGLIHUHQFLDFLyQGHORYDULRTXHRFXUUHHQHOIHWR
FRQ67LQLFLDQRUPDOPHQWHHQODVHPDQDGHJHVWDFLyQODV
FpOXODVJHUPLQDOHVPLJUDQDODVFUHVWDVJHQLWDOHV\DODVH-
PDQDGHJHVWDFLyQLQLFLDXQDGHJHQHUDFLyQSUHPDWXUDGH
ORVIROtFXORVGHORYDULRORVTXHVRQUHHPSOD]DGRVSRUDEXQ-
WDODXPHQWRHQODWUDQVOXFHQFLDQXFDOHKLJURPDTXtVWLFR
WDPELpQSXGLHUDHQFRQWUDUVHFRDUWDFLyQGHODDRUWDDQRPD-
OtDVUHQDOHVSROLKLGUDPQLRV\UHWDUGRHQHOFUHFLPLHQWRLQ-
WUDXWHULQRDGHPiVGHORVUHVXOWDGRVGHOWULSOHRFXiGUXSOH
PDUFDGRUPDWHUQRDOIDIHWRSURWHtQDK*&LQKLELQD$\HV-
GDQWHWHMLGRFRQHFWLYRHVWUtDVJRQDGDOHVORTXHUHVXOWDHQ
IDOODRYiULFD
(QHOPRPHQWRGHODSXEHUWDGQRVHSURGXFHHODXPHQWR
GHORVQLYHOHVHVWURJpQLFRVSRUORTXHQRVHSURGXFHHOFUH-
FLPLHQWR\PDGXUDFLyQGHO~WHURYDJLQD\PDPDV/DVKRU-
WULROQRFRQMXJDGR'HVSXpVGHOQDFLPLHQWRGHODO PRQDVKLSRÀVLDULDVTXHFRQWURODQODIXQFLyQRYiULFD/+\
Documento descargado de http://www.elsevier.es el 20/06/2016. Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato.

 )3pUH]%XHQRHWDO

SDUWLFXODUPHQWH)6+HVWiQDXPHQWDGDV(VWHDXPHQWRHV\D
Tabla 1 )HQRWLSRGHOVtQGURPHGH7XUQHU
aparente en los primeros meses de vida, como resultado de
ODLQYROXFLyQRYiULFD'XUDQWHODLQIDQFLDHQWUHORV\ORV +DOOD]JR )UHFXHQFLD
DxRVORVQLYHOHVGH/+\)6+VRQQRUPDOHVDXQTXHGHVSXpV
(VWDWXUDEDMD 100
GHODDGPLQLVWUDFLyQGH*Q5+VHREVHUYDXQDXPHQWRGH
DPEDVHQPD\RUJUDGRTXHHQVXMHWRVQRUPDOHV'HVSXpVGH ,QIHUWLOLGDG 
ORVDxRVGHYLGDORVQLYHOHVFRPLHQ]DQDDXPHQWDUQXHYD- )DOORRYiULFRSUHPDWXUR 90-96
mente por encima de la normalidad; por ello, a esta edad, 0DQRV\SLHVKLQFKDGRV 80
ODGHWHUPLQDFLyQGHODVJRQDGRWURSLQDVSXHGHWHQHUYDORU 7yUD[DQFKR 80
GLDJQyVWLFR(OPHFDQLVPRGHIHHGEDFNHQWUHHORYDULR\ORV
0DPDVKLSRSODVLFDV\PX\VHSDUDGDV 80
FHQWURVUHJXODGRUHVKLSyÀVLVHKLSRWiODPRHVWpLQWDFWROR
TXHVHGHPXHVWUDSRUHOKHFKRGHTXHODVJRQDGRWURSLQDV /tQHDSRVWHULRUGHOFDEHOOREDMD 80
pueden reducirse a niveles normales con el tratamiento sus- 5RWDFLyQ\IRUPDDQRUPDOGHODVRUHMDV 80
WLWXWLYRFRQHVWUDGLRO\SURJHVWHURQD 0DQGtEXODLQIHULRUEDMD 
/DWDVDGHHVWUDGLROHVPX\YDULDEOH\QRVHFRUUHODFLRQD %UD]RVKDFLDHOH[WHULRUHQVXXQLyQFRQHO
FRQODWDVDEDVDOGHJRQDGRWURSLQDV/RVQLYHOHVGHDQGUyJH- KRPEUR 
QRVVXSUDUUHQDOHVVRQQRUPDOHV\VHHOHYDQHQODDGUHQDU-
8xDVGpELOHV\GREODGDVKDFLDDUULED 
TXLD SHUR SRU HQFLPD GH ORV  DxRV ORV QLYHOHV GH
2VWHRSHQLD2VWHRSRURVLV\IUDFWXUDVD
WHVWRVWHURQDDQGURVWHQHGLRQD\GHKLGURHSLDQGRVWHURQDVRQ
edades tempranas 50-80
EDMRVDFDXVDGHODKLSRIXQFLyQRYiULFD
$PHGLDGRVGHODGpFDGDGHORV·VVHVXJLULyTXHODGLV- 'HGRVDQXODUHVFRUWRV 60
minución del crecimiento en las pacientes con ST se relacio- Hipertensión arterial 50
QDEDFRQXQDEDMDSURGXFFLyQGH*+DOÀQDOGHODQLxH]\ 1HYRVSLJPHQWDGRV 50
SULQFLSLRGHODDGROHVFHQFLDVLQHPEDUJRHVSUREDEOHTXH &XELWRYDOJR 
VHDGHELGRDODIDOWDGHODXPHQWRLQGXFLGRGHODVHFUHFLyQ
Anormalidades cardiacas 
GH*+SRUHVWHURLGHVVH[XDOHVHQHOSHULRGRSXEHUDO7DP-
ELpQSRGUtDLQÁXLUHQHVWHVHQWLGRHOH[FHVRGHSHVRTXH &XHOORFRUWR 
VXHOHQSUHVHQWDUHVWDVSDFLHQWHV3DUHFHVHUSRFRSUREDEOH Anomalías renales 
TXHH[LVWDXQGpÀFLWHQODFDSDFLGDGSDUDVLQWHWL]DU,*)R %yYHGDGHOSDODGDUHVWUHFKD 38-50
GHUHVSRQGHUDOD,*),\DTXHODVHFUHFLyQGHHVWHLQGXFLGD 2EHVLGDG 30
SRU*+SDUHFHVHUQRUPDODVtFRPRODVHQVLELOLGDGFHOXODUD
Sordera neurosensorial 
OD,*)6.
8QRVQLYHOHVGHKRUPRQDGHOFUHFLPLHQWRDGHFXDGRVTXH ,QWROHUDQFLDDFDUERKLGUDWRV 15-50
HVWiQDVRFLDGRVDXQDSURGXFFLyQQRUPDOGHHVWHURLGHVVH- Hipotiroidismo 15-30
[XDOHVVRQQHFHVDULRVSDUDTXHRFXUUDHOHSLVRGLRGHFUHFL- (VWUDELVPR 18
PLHQWRTXHVHSUHVHQWDGXUDQWHODSXEHUWDG\TXHHV Escoliosis 10
FRQRFLGRFRPRHOHVWLUyQSXEHUDO *RQDGREODVWRPD 
'LDEHWHVPHOOLWXVWLSR 5-10
Alopecia 2-5
Fenotipo - clínica 9LWtOLJR 3-5
Psoriasis <5
/DPD\RUtDGHORVSHGLDWUDVHVWiQIDPLOLDUL]DGRVFRQODVFD- Artritis reumatoide juvenil <5
UDFWHUtVWLFDVFOtQLFDVFOiVLFDVGHO67SRUORTXHHOGLDJQyVWL-
(QIHUPHGDGFHOLDFD 
FRVHVRVSHFKDVREUHWRGRSRUODWDOODEDMDOLQIHGHPDGH
PDQRV\SLHVFXHOORDODGROtQHDGHLPSODQWDFLyQGHOFDEH-
OOREDMDHQHOFXHOOR\F~ELWRYDOJR(QODWDEODVHPXHV-
WUDQDOJXQDVGHODVDQRPDOtDVFOtQLFDV\ODIUHFXHQFLDFRQ
que se presentan. SRQWDQHDRFXUULyHQHOGHODVSDFLHQWHV\HO
/DSUHVHQWDFLyQFOtQLFDYDUtDFRQODHGDG'HVGHHOSHULR- UHTXLULyWHUDSLDHVWURJpQLFDSDUDSUHVHQWDUODSXEDUFD$XQ-
GRGHODLQIDQFLDHVPX\FDUDFWHUtVWLFRODWDOODEDMDPRWLYR TXHHQRWUDVVHULHVVHKDYLVWRTXH~QLFDPHQWHHO
SRUHOTXHHQWRGDQLxDFRQWDOODFRUWDGHEHFRQVLGHUDUVHHQ SUHVHQWDQSXEHUWDGHVSRQWiQHD/DFRQFOXVLyQHVTXHWRGDV
HOGLDJQyVWLFRGLIHUHQFLDOHO67VREUHWRGRVLVHDFRPSDxD ODVSDFLHQWHVFRQ67QHFHVLWDQHVWUyJHQRVH[yJHQRV
de soplo cardiaco. El retraso de la menarquia con talla corta /DPD\RUtDGHODVSDFLHQWHVFRQ67WLHQHQLQWHOLJHQFLD
GHEHFRQVLGHUDUVHFRPR67PLHQWUDVQRVHGHPXHVWUHOR
FRQWUDULR/DSUHVHQFLDGHYHOORD[LODU\S~ELFRQRGHEHFRQ-
VLGHUDUVHFRPRHYLGHQFLDGHSXEHUWDGSXHVVHGHEHQDOD
SUHVHQFLDGHDQGUyJHQRVGHRULJHQDGUHQDO. En las mujeres
DGXOWDVFRQWDOODFRUWDFRQLQIHUWLOLGDGRLUUHJXODULGDGHVHQ
ODPHQVWUXDFLyQGHEHGHVFDUWDUVH671RREVWDQWHDOJXQDV
PXMHUHVFRQ67WLHQHQPHQDUTXLD'D6LOYD1HJUHLURV\FROV8
HYDOXDURQSDFLHQWHV\HQFRQWUDURQTXHODSXEHUWDGHV-
QRUPDO,4DXQTXHSXHGHQH[LVWLUWUDVWRUQRVGHDSUHQ-
GL]DMHVREUHWRGRHQORTXHVHUHÀHUHDODSHUFHSFLyQHVSD-
FLDOOHFWXUDFRRUGLQDFLyQYLVXDOPRWRUD\PDWHPiWLFDV
7DPELpQSXHGHQSUHVHQWDUKLSHUDFWLYLGDGLQPDGXUH]DQ-
VLHGDG\GHSUHVLyQ9/HSDJH10HQFRQWUyHQXQHVWXGLRGH
SDFLHQWHVFRQ67\XQJUXSRFRQWUROGHSDFLHQWHVTXHODV
PXMHUHVFRQ67MyYHQHV\DGROHVFHQWHVSUHVHQWDEDQXQDUH-
GXFFLyQGHOYROXPHQGHPDWHULDJULVPDWHULDEODQFD\iUHD
Documento descargado de http://www.elsevier.es el 20/06/2016. Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato.
5HHPSOD]RHVWURJpQLFRHQSDFLHQWHVFRQVtQGURPHGH7XUQHU
GHVXSHUÀFLHVREUHODFRUWH]DSDULHWDO\RFFLSLWDOTXHSXGLH-
UDVHUFRQVHFXHQFLDGHODGHÀFLHQFLDGHHVWUyJHQRV/DVFD-
UDFWHUtVWLFDVFOtQLFDVYDUtDQVHJ~QODDQRPDOtDFLWRJHQpWLFD
TXHSUHVHQWDODSDFLHQWHFRQ67/RVKDOOD]JRVFOtQLFRVFD-
UDFWHUtVWLFRVORVSUHVHQWDQODVSDFLHQWHVFRQPRQRVRPtD;\
de la variedad con isocromosoma del Xq; los pacientes con
GHOHFLyQGHO;SSUHVHQWDQVREUHWRGRHVWDWXUDFRUWD\PDO-
IRUPDFLRQHVFRQJpQLWDV\DTXHOODVFRQGHOHFLyQGH;TDPH-
QXGRVRORSUHVHQWDQGLVJHQHVLDJRQDGDO
Calidad de vida
(QXQHVWXGLR0H[LFDQRTXHLQFOX\RSDFLHQWHVFRQ67GH
HGDGHVHQWUH\DxRVVHHQFRQWUyXQDXVHQWLVPRHVFRODU
\ODERUDOHQGHODVSDFLHQWHVVLHQGRODFDXVDPiVFR-

GHEDMRGHODSHUFHQWLOSDUDODHGDG6HDSOLFDSRUYtDVXE-
FXWiQHDHQXQDGRVLVGHPJNJSRUVHPDQD
/DWDOODDGXOWDGHSHQGHGHODWDOODDOLQLFLRGHOWUDWDPLHQ-
WRUHVSXHVWDHQHOSULPHUDxRWDOODJHQpWLFDHGDGDOLQLFLR
GHOWUDWDPLHQWRGRVLVPHGLDVHPDQDOGHO*+HGDGDOÀQDOL-
]DUHOWUDWDPLHQWRXVRGHR[DQGURORQDFX\DDSOLFDFLyQDXQ
HVWiHQGHEDWH\SHVRDOQDFLPLHQWR(OFDULRWLSRQRKDPRV-
WUDGRQLQJXQDLQÁXHQFLD13.
/RVHIHFWRVDGYHUVRVGHHVWDWHUDSLDLQFOX\HQKLSHUWHQVLyQ
LQWUDFUDQHDOHVFROLRVLVGHVOL]DPLHQWRGHODHStÀVLVGHOD
FDEH]DIHPRUDO\PHWDEROLVPRDQRUPDOGHJOXFRVD
Tratamiento del hipogonadismo
(OREMHWLYRGHODWHUDSLDKRUPRQDOGHUHHPSOD]RHVVLPXODU
ODSXEHUWDGQRUPDOLQFOX\HQGRODVVLJXLHQWHVPHWDV
P~QODQHFHVLGDGGHDWHQFLyQPpGLFDXQH[-
SUHVDURQTXHKDQVLGRREMHWRGHEXUODGHFRPSDxHURVGH
WUDEDMRHVFXHODRIDPLOLDUHVUHÀULHURQVHQWLUVHLQVD-
WLVIHFKDVFRQVXYLGD\DSHVDUGHHVWRQREXVFyDSR\R
HQXQJUXSRGHD\XGD(QODSREODFLyQWRWDOVHUHILULyXQ
JDVWRPHQVXDODOWRSDUDPHGLFDPHQWRVUHODFLRQDGRVFRQVX
DWHQFLyQVLQLQFOXLUHOFRVWRGHODKRUPRQDGHFUHFLPLHQWR
ODFXDOIXHUHFLELGDHQDOJ~QPRPHQWRGHVXYLGDHQHO
GHODVSDFLHQWHVPLHQWUDVTXHGHODVPD\RUHVD
DxRVUHFLELHURQWHUDSLDFRQHVWUyJHQRV3.
‡ ,QGXFLU\PDQWHQHUXQGHVDUUROORVH[XDO\VDQJUDGRXWHUL-
no cíclico.
‡ Permitir un pico de densidad mineral ósea adecuada para
SUHYHQLUODSpUGLGDGHPDVDyVHD\ODQHFHVLGDGGHWUDWD-
PLHQWRGHRVWHRSHQLDRVWHRSRURVLV\IUDFWXUDVDIXWXUR
‡ 0DQWHQHUXQDGHFXDGRGHVDUUROORGHODSLHO\PXVFXODWX-
ra.
‡ 0DQWHQHU\GHVDUUROODUODPHPRULDUHODFLRQDGDDODRUJD-
QL]DFLyQ\SODQWHDPLHQWRGHPHWDVIXWXUDV0HPRULDGH
(QXQHVWXGLRHQSREODFLyQFRQKLSRJRQDGLVPRFRQJpQLWR
GRQGHVHLQFOX\HURQSDFLHQWHVFRQ6[GH7XUQHU\SD-
FLHQWHVFRQKLSRJRQDGLVPRSRURWUDVFDXVDVVHHQFRQWUy
TXHODVSDFLHQWHVFRQ67WXYLHURQPHQRUH[FLWDFLyQTXHOD
SREODFLyQJHQHUDOSHURODVSDFLHQWHVFRQRWUDFDXVDGHKL-
SRJRQDGLVPRSUHVHQWDURQD~QPHQRUH[FLWDFLyQVH[XDORU-
JDVPR\GRORU11.
Tratamiento
El tratamiento de las pacientes con ST requiere la valora-
FLyQ\VHJXLPLHQWRSHULyGLFRDGLIHUHQWHVHGDGHV$GHPiV
GHVHUXQPDQHMRPXOWLGLVFLSOLQDULRFRPR\DVHKDPHQFLR-
nado anteriormente nosotros nos centraremos en la terapia
KRUPRQDOGHUHHPSOD]R
Tratamiento de la talla baja
WUDEDMR15.
‡ 3UHYHQFLyQGHHQIHUPHGDGHVFDUGLRYDVFXODUHV
‡ )DFWRUSURWHFWRUGHULHVJRVSDUDFiQFHU(QGRPHWULDO\
RYiULFR
/DLQGXFFLyQGHODSXEHUWDGFRPLHQ]DDODHGDGGH
DxRVSDUDWUDWDUGHVLPXODUORPD\RUSRVLEOHDODSXEHUWDG
QDWXUDO/DHGDGGHLQLFLRSXHGHVHUDQWHULRURSRVWHULRUHQ
IXQFLyQGHIDFWRUHVLQGLYLGXDOHV3DUDODHGDGGHLQLFLRVH
EXVFDHOHTXLOLEULRHQWUHPRPHQWRySWLPRSDUDHOiPELWR
SVLFROyJLFRODIRUPDFLyQGHKXHVR\ODHVWDWXUD$QWHVGH
LQLFLDUODLQGXFFLyQGHODSXEHUWDGVHWHQGUiQTXHGHWHUPL-
QDU/+\)6+SDUDH[FOXLUPDGXUDFLyQWDUGtD
/DIRUPXODFLyQRSWLPDGHHVWUyJHQRVGRVLVYtDGHDGPL-
QLVWUDFLyQ\WLHPSRGHLQLFLRGHSURJHVWHURQDHVFRQWURYHU-
VLDO$OLQLFLRVHFRPLHQ]DFRQXQDGRVLVEDMDGHHVWUyJHQR
TXHGXUDQWHXQSHUtRGRGHDxRVVHHOHYDUDDODGRVLÀFD-
FLyQSDUDDGXOWRV/DPD\RUtDGHORVH[SHUWRVHQHOWHPD
UHFRPLHQGDQTXHVHLQLFLHFRQDGHODGRVLVGH
VXVWLWXFLyQGHODGXOWRVHJXLGRGHXQDXPHQWRJUDGXDOHQXQ
SHULRGRGHDxRV
/DWHUDSLDFRQKRUPRQDGHOFUHFLPLHQWR*+FXDOIXHDSUR- (OHIHFWRGHORVHVWUyJHQRVHVHQUHDOLGDGELIiVLFRSRU
EDGDSRUOD)'$HQ/DWDOODGHODVSDFLHQWHVVDMRQDV XQDSDUWHHVWLPXODQHOFUHFLPLHQWRHQEDMDVGRVLV
FRQ67HQSURPHGLRHVGHFP&RQOD*+VHREWLHQHXQD GHODGRVLVGHVXVWLWXFLyQDGXOWD\SRURWUDSDUWHDDOWDV
WDOODÀQDOPHGLDGH\FRQ*+PiVR[DQGURORQD
FDVLFPPiVTXHORVFRQWUROHVKLVWyULFRV12.
/DDFHOHUDFLyQGHODYHORFLGDGGHFUHFLPLHQWRHVFRQWHP-
SRUiQHDDOLQLFLRSXEHUDOVHJXLGDSRUXQDIDVHGHHQOHQWH-
FLPLHQWRKDVWDHOFLHUUHGHORVFDUWtODJRVGHFUHFLPLHQWR
'XUDQWHODSXEHUWDGODJDQDQFLDHQWDOODHVGHDSUR[LPDGD-
PHQWHFP/DVQLxDVFRQ67QRSUHVHQWDQHOHVWLUyQSXEH-
UDOORTXHVXPDGRDVXWDOODEDMDSUHYLDH[SOLFDORVFP
EDMRODPHGLDGHODWDOODIDPLOLDU
GRVLVVREUHSPROOW>QJG/@VRQLQKLELGRUHVGHOFUH-
cimiento16.
3DUDODVXVWLWXFLyQGHHVWUyJHQRVKD\GLIHUHQWHVSUHSD-
UDFLRQHVGLVSRQLEOHV7tSLFDPHQWHVHXWLOL]DODIRUPDRUDO
GHOEHWDHVWUDGLROHVWDSUHSDUDFLyQHVLGpQWLFDDODGH
HVWUDGLROGHRULJHQQDWXUDO\WLHQHORVHIHFWRVEHQpÀFRV
GHORVHVWUyJHQRVHVVHJXURGHXVDU\QRWLHQHHIHFWRV
FRODWHUDOHVVREUHORVSDUiPHWURVPHWDEyOLFRVGHORVIDF-
WRUHVGHFRDJXODFLyQ\ORVQLYHOHVGHOLSRSURWHtQDVGHDOWD
/DWHUDSLDFRQKRUPRQDGHOFUHFLPLHQWRUHFRPELQDQWH GHQVLGDG+'/DVtFRPRDXPHQWDUODGHQVLGDGyVHD/D
KXPDQDGHEHGHLQLFLDUWDQSURQWRFRPRODWDOODHVWHSRU YHQWDMDGHODSUHSDUDFLyQWUDQVGpUPLFDHVTXHQRWLHQH
Documento descargado de http://www.elsevier.es el 20/06/2016. Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato.
126
QLQJ~QHIHFWRGHSULPHUSDVRHQHOKtJDGRFDXVDQGRPH-
QRVLQGXFFLyQGHSURWHtQDVKHSiWLFDV3XHGHXWLOL]DUVH
HVWUyJHQRVHTXLQRVFRQMXJDGRVSHURVXIRUPXODFLyQFRQ-
WLHQHP~OWLSOHVVXVWDQFLDVHVWURJpQLFDVFRQGLIHUHQWHVSR-
WHQFLDVELROyJLFDVTXHSXHGHQQRVHULQGLFDGDVHQHVWD
SREODFLyQ
+D\FRQWURYHUVLDGHFXDOYtDHVODPiVDGHFXDGDHQXQ
HVWXGLRGH7RUUHV6DQWLDJR\7DERDGD en donde participa-
URQSDFLHQWHVFRQ67GH“DxRVGHHGDGVHHQ-
FRQWUyTXHDPERVJUXSRVWXYLHURQFRQFHQWUDFLRQHVGH
HVWUDGLROQRUPDOHVGHVSXpVGHDPHVHVHOSRUFHQWDMH
)3pUH]%XHQRHWDO
‡ PHVHVDQWHVGHGRUPLUFRUWDUHOSDUFKHGH
PFJHQGRVSDUWHVLJXDOHV\FRORFDUDPEDVSDUWHVSRU
ODPDxDQDTXLWDUXQDSDUWH\VRORDQWHVGHGRUPLUYRO-
verla a colocar.
‡ 36 meses
— YHFHVSRUVHPDQDSDUFKHGHPFJR
— SDUFKHSRUVHPDQDGHPFJ
0pWRGRGHDGPLQLVWUDFLyQHOSDUFKHGHEHFRORFDUVHHQ
XQDSDUWHQRGDxDGDGHODSLHOHQXQOXJDUTXHQRVHDGH-
PDVLDGRPyYLOSDUWHVXSHULRUGHJO~WHRVDEGRPHQHVSDO-
FRUSRUDOGHJUDVDOD'02\R[LGDFLyQGHOtSLGRVIXHURQVLPL- GDFRORFDUHOQXHYRSDUFKHHQRWUDSDUWHGHODSLHO
ODUHVHQDPERVJUXSRV(O,*)IXHPiVEDMRFRQHOHVWUD-
GLRO RUDO SHUR OD VXSUHVLyQ GH JRQDGRWURSLQDV IXH 7HUDSLDFRQ(WLQLOHVWUDGLROSUHVHQWDFLyQHQFiSVXODV
FRPSDUDEOH(OHVWULRO\6+%*IXHURQPiVDOWDVHQHOJUXSR ‡ $xRPFJNJGtD
GHWHUDSLDRUDO/DYtDWUDQVGpUPLFDUHVXOWyPiVÀVLROyJLFD ‡ $xRPFJNJGtD
TXHODYtDRUDO(QRWURHVWXGLRHOHVWUDGLROWUDQVGpUPLFR ‡ $xRPFJNJGtD
UHVXOWyHQPD\RU'02DVtFRPRPD\RUHVLQFUHPHQWRVHQOD ‡ $xRPFJNJGtD
WDOODÀQDO\HOYROXPHQXWHULQR18. ‡ 'RVLVSDUDDGXOWRVPJSRUGtD
/DDGPLQLVWUDFLyQRUDOGHHVWUDGLROFRQGXFHDODFRQFHQ-
WUDFLyQIDUPDFROyJLFDGHODKRUPRQDHQODYHQDSRUWDODQWHV 9tDWUDQVGpUPLFDFRQ*HOGHEHWDHVWUDGLRO
GHTXHVHPHWDEROLFHHQHOKtJDGRHVWHSULPHUSDVRUHVXOWD ‡ PJHOSULPHUDxR
HQXQDXPHQWRGHODSURGXFFLyQKHSiWLFDGHJOREXOLQDV ‡ PJHOVHJXQGRDxR
WUDQVSRUWDGRUDVGHYDULDVKRUPRQDVIDFWRUHVGHFRDJXOD- ‡ PJHOWHUFHUDxR
FLyQOLSRSURWHtQDV\DQJLRWHQVLQyJHQRHIHFWRVTXHVRQHYL- ‡ PJHOFXDUWRDxR
WDGRVYtDWUDQVGpUPLFD19. ‡ PJHOTXLQWRDxR
$FRQWLQXDFLyQSUHVHQWDPRVDOJXQRVGHORVHVTXHPDVPiV
XWLOL]DGRVDXQTXHFRPRKHPRVPHQFLRQDGRQRKD\XQ 6HSXHGHLQLFLDUFRQGRVLVGHHVWUDGLROHQSDUFKHGH
FRQVHQVR\FDGDH[SHUWRXWLOL]DDOJ~QHVTXHPDVHJ~QVX PFJNJVHSXHGHWRPDUGHWHUPLQDFLyQVpULFDGHHVWUDGLRO
SURSLDH[SHULHQFLD GHVSXpVGHVHPDQDVORTXHKDFHSRVLEOHDMXVWDUODGRVLV
individualmente; si el desarrollo mamario inicia dentro de
$GPLQLVWUDFLyQRUDOGHEHWDHVWUDGLROWDEOHWDVPJ ORVSULPHURVPHVHVVHGHEHFRQVLGHUDUUHGXFLUODGRVLV21.
␤-estradiol. (QXQHVWXGLRGRQGHSDUWLFLSDURQQLxDVGHHQWUH\
DxRVHQWUDWDPLHQWRFRQ*+\GDWRVGHLQVXÀFLHQFLDRYiULFD
Esquema: )6+HOHYDGDVHOHVLQGXMRHOGHVDUUROORSXEHUDOXWLOL]DQGRHQ
‡ 1erDxRPFJNJGtD ODPLWDGGHHOODVXQDGRVLVLQGLYLGXDOL]DGDGHPFJNJ
‡ žDxRPFJNJGtD SRUGtDGXUDQWHDxRV\HQHORWURJUXSRVHXWLOL]yXQDGRVLV
‡ 3erDxRPFJNJGtD ÀMDGHPJGLDULRVGXUDQWHHOSULPHUDxRVHJXLGRGH
‡ žDxRPFJNJGtD PJGLDULRVGXUDQWHHOVHJXQGRDxRVHREVHUYyTXHHOLQLFLR
‡ 'RVLVGHDGXOWRVPJGtD GHOGHVDUUROORGHFDUDFWHUHVVH[XDOHVPHGLGRSRUHVFDODGH
7DQQHULQLFLRDQWHVHQHOJUXSRGHGRVLVÀMDVGtDVYVHO
(VTXHPDGHGRVLÀFDFLyQWUDQVGpUPLFD20: JUXSRGHGRVLVLQGLYLGXDOL]DGRGtDVS ODHGDG
‡ /RVSULPHURVPHVHVVHDSOLFDHOSDUFKHDQWHVGH yVHDQRPRVWUyDFHOHUDFLyQLQDGHFXDGD\QRKXERDOWHUDFLyQ
GRUPLUSDUDHOLPLQDUVHDODPDxDQDVLJXLHQWH HQODHVWDWXUDHVSHUDGDHQQLQJXQRGHORVJUXSRV22.
— NJGHOSDUFKHGHPFJ PFJ
— NJGHOSDUFKHGHPFJ PFJ
— !NJóGHSDUFKHPFJ PFJ
Tratamiento con progestágenos
‡ PHVHVDSOLFDUDQWHVGHGRUPLUUHWLUDUODPDxDQD
VLJXLHQWH (VWHWUDWDPLHQWRVHFRPLHQ]DGRVDxRVGHVSXpVGHLQLFLDUOD
— 6LVHLQLFLDHOSULPHUDxRFRQDXPHQWDUD WHUDSLDFRQHVWUyJHQRVRDQWHVVLVHSURGXFHVSRWWLQJ'HEH
GHOSDUFKHGHPFJ PFJ FRLQFLGLULGHDOPHQWHFRQXQDHFRJUDItDJLQHFROyJLFDTXH
— 6LKDLQLFLDGRFRQDXPHQWDUDóGHOSDUFKHGH PXHVWUHXQ~WHUR!PP\XQHQGRPHWULRPD\RUGHPP
PFJ PFJ 1XHYDPHQWHVHSUHÀHUHQORVSURJHVWiJHQRVQDWXUDOHVVH
— 6LVHLQLFLDFRQóSDVHDODPLWDGGHOSDUFKHGH GDQGXUDQWHGtDVDOPHVVREUHWRGRVLVHGHVHDKHPR-
PFJ PFJ UUDJLDSRUGHSULYDFLyQ/RVHVTXHPDVPiVXWLOL]DGRVVRQ
‡ 18-30 meses:
— 6LVHXVyDORVPHVHVSDUWHGHOSDUFKHGH ‡ 'LGURJHVWHURQD'XSKDVWRQ®PJGtDGHOGtDDO
PFJSDVDUDó PFJ GHOPHVFRQHVWUyJHQRVFRQWLQXRV(VHOPiVXWLOL]DGR
— 6LVHDGPLQLVWUyóXVDUODPLWDGGHOSDUFKH  SRUTXHHVORPiVVLPLODUDODSURJHVWHURQDQDWXUDO3XHGH
PFJ GDUODKLQFKD]yQFRPRHIHFWRVHFXQGDULR
— Si durante los 12-18 meses se administro la mitad, ‡ 3URJHVWHURQDPLFURQL]DGD*HVOXWLQ®LGpQWLFDDODSUR-
XWLOL]DUôGHOSDUFKH PFJ JHVWHURQDODGRVLVHVJHQHUDOPHQWHPJSRUGtDSRUOD
Documento descargado de http://www.elsevier.es el 20/06/2016. Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato.

5HHPSOD]RHVWURJpQLFRHQSDFLHQWHVFRQVtQGURPHGH7XUQHU 

QRFKHDQWHVGHDFRVWDUVHVLIXHUDQHFHVDULRPJSRU FLyQTXHQRUPDOPHQWHVHLQLFLDHQHOVHJXQGRRWHUFHUGtD
ODPDxDQDGHOGtDDOFRQHVWUyJHQRVFRQWLQXRV GHVSXpVGHOD~OWLPDWDEOHWDTXHFRQWLHQHHOLQJUHGLHQWH
‡ 0HGUR[LSURJHVWHURQD3URYHUD®GHPJSRUGtDVDO activo.
PHVFRQHVWUyJHQRVFRQWLQXRV &RQXQDSDFLHQWH;2VLQHOGHVDUUROORSXEHUDO\ODPH-
‡ 1RUHWLVWHURQDPJ3ULPROXW®1RU/RVHVWXGLRVHQDQL-
PDOHVKDQGHPRVWUDGRTXHWLHQHOLJHURHIHFWRUHVLGXDO
DQGURJpQLFR
Terapia de reemplazo hormonal cícliclo
vs continuo
$OSUHVFULELUODWHUDSLDGHUHHPSOD]RKRUPRQDOVHSXHGHKD-
FHUODGLVWLQFLyQHQWUHXQDDGPLQLVWUDFLyQELIiVLFDFRQHVWUy-
JHQRFRQWLQXR\SURJHVWLQDGXUDQWHGtDVSRUFLFOR\HO
HVTXHPDFRQWLQXRFRQHOXVRGHHVWUyJHQRV\SURJHVWiJHQRV
GHPDQHUDFRQWLQXD(OXVRFRQWLQXRSURGXFHXQULHVJRGH
VDQJUDGRLUUHJXODUHVSHFLDOPHQWHGXUDQWHHOSULPHUDxRGH
XVRGHXQIUHQWHDTXHSURGXFHQORVELIiVLFRV23.
Efectos de reemplazo estrogénico a baja dosis
durante la infancia
&RPR\DPHQFLRQiEDPRVDQWHULRUPHQWHODGLVJHQHVLDRYiUL-
FDTXHDIHFWDDOGHQXHVWUDVSDFLHQWHVFRQ67UHVXOWDHQ
XQDGHÀFLHQFLDHVWURJpQLFDGHVGHODLQIDQFLD\TXHUHVXOWD
HQHIHFWRVSHUMXGLFLDOHVHQGLYHUVRVWHMLGRVSRUORTXHHQORV
~OWLPRVDxRVVHKDQOOHYDGRDFDERHVWXGLRVGHORVHIHFWRV
GHOUHHPSOD]RHVWURJpQLFRXWLOL]DQGRXOWUDEDMDVGRVLV
(Q,QGLDQiSROLVVHUHDOL]yXQHVWXGLRHQSDFLHQWHV
GHHOODVUHFLELHURQSODFHER\ODVUHVWDQWHVUHFLELHURQ
QDUTXLDHVSRQWiQHDODSRVLELOLGDGGHHPEDUD]RHVFDVLQXOD
HQFRQVHFXHQFLDGHVSXpVGHODLQGXFFLyQGHSXEHUWDGQRVH
UHFRPLHQGDQLQJXQDLQGLFDFLyQGHDQWLFRQFHSWLYRVRUDOHV\
GHEHFRQWLQXDUFRQWHUDSLDGHUHHPSOD]RKRUPRQDO
(QODVPXMHUHVFRQPRVDLFRTXHWXYLHURQSXEHUWDGHVSRQ-
WiQHD\WLHQHQVXSURSLRFLFORDXQTXHHVUDURVHSXHGHQ
XWLOL]DUDQWLFRQFHSWLYRVRUDOHVFXDQGRQRKD\GHVHRGHWHQHU
KLMRV6LHQODVHPDQDGHGHVFDQVRVXUJHQVtQWRPDVPHQRSiX-
VLFRVWDOHVFRPRVRIRFRV\VXGRUHVQRFWXUQRVVHOOHYDUiD
FDERXQDHYDOXDFLyQGHODIXQFLyQGHODUHVHUYDRYiULFD\VH
FRQVLGHUDUDXQFDPELRDODSUHSDUDFLyQFRQWLQXD
Aquellos adolescentes que presentan un aumento del ries-
JRGHWURPERVLV\RXQDFRDJXORSDWtDQRVHUHFRPLHQGDHO
XVRGHDQWLFRQFHSWLYRVSHURVLHVIDFWLEOHHOXVRGH7+5SRU
YtDWUDQVGpUPLFDDVRFLDGRDSURJHVWiJHQRVHQIRUPDFtFOLFD26.
/DVStOGRUDVGHFRPELQDFLyQFRQPLFURJUDPRVGHHWLQL-
OHVWUDGLROSURSRUFLRQDQPD\RUFRQWUROGHOFLFORTXHODVStO-
GRUDVFRPELQDGDVTXHFRQWLHQHQPLFURJUDPRVODVFXDOHV
GDQXQPD\RUULHVJRGHVDQJUDGRLUUHJXODU\PHWURUUDJLD/D
QXHYDStOGRUDFRQYDOHUDWRGHHVWUDGLROGLHQRJHVW4ODLUD®)
HQFRPSDUDFLyQFRQXQDStOGRUDGHPFJGHHWLQLOHVWUD-
GLROOHYRQRUJHVWUHOPXHVWUDUHOHYDQWHVYHQWDMDVHQWpUPL-
nos de control del ciclo.
Riesgos de la terapia hormonal de reemplazo
en pacientes con síndrome de Turner
1RVHFXHQWDFRQHVWXGLRVVLJQLÀFDWLYRVVREUHORVULHVJRV\
PFJNJGtDQJGHORVDORVDxRV\PFJ
NJGtDGHORVDORVDxRVHVWDVGRVLVIXHURQUHGXFLGDVDO
HQPHQRUHVGHDxRVTXHSUHVHQWDURQGHVDUUROORPD-
PDULRVDQJUDGRYDJLQDO\HQPHQRUHVGHDxRVTXHWXYLH-
URQXQDYDQFHUiSLGRHQODHGDGyVHDODVQLxDVTXH
UHFLELHURQHVWUyJHQRVWXYLHURQXQDWHODUFDPiVWHPSUDQD
HIHFWRVVHFXQGDULRVGHORVDQWLFRQFHSWLYRVKRUPRQDOHV\OD
WHUDSLDGHUHHPSOD]RKRUPRQDOHQPXMHUHVFRQVtQGURPHGH
7XUQHU&DVLWRGDVODVUHFRPHQGDFLRQHVVHEDVDQHQHVWXGLRV
KHFKRVHQSDFLHQWHVVDQDV(VQHFHVDULRWRPDUHQFXHQWD
TXHSDFLHQWHVFRQ67HVWiQH[SXHVWDVDODWHUDSLDHVWURJpQL-
FDGXUDQWHGpFDGDV%iVLFDPHQWHVHUtDQORVPLVPRVULHVJRV
YVDxRV\XQULWPRPiVOHQWRGHSXEHUWDGYV GHXVRDFXDOTXLHUHGDGGHSHQGLHQGRGHOHVWUyJHQRXWLOL]D-
DxRVDPERVJUXSRVWXYLHURQPHQDUFDWDUGtDDxRV
DGHPiVGHORVHIHFWRVPHQFLRQDGRVHQODFDSDFLGDGFRJQLWL-
YD\ODJDQDQFLDGHHVWDWXUDPHGLDGDSRUKRUPRQDGHFUHFL-
miento.
(QXQ(VWXGLRGH.RGDPD\FROV25TXHLQFOX\ySDFLHQ-
WHVVHXWLOL]yXQDGRVLVGHDGXOWRHQSDFLHQWHVPRVWUDQ-
GRODGRVLV\ODYtDGHDGPLQLVWUDFLyQ
+DVWDHOPRPHQWRQRVHKDQUHSRUWDGRSDFLHQWHVFRQFiQ-
FHUGHPDPDHQORVHVWXGLRVUHDOL]DGRV([LVWHHOULHVJRGH
KLSHUSODVLDHQGRPHWULDOSRUXVRGH(VWUyJHQRVSHURHVWH
ULHVJRHVFRQWURODEOHFRQSURJHVWiJHQRVFtFOLFRV
(OULHVJRGHWURPERHPEROLVPRYHQRVRFRQORVDQWLFRQFHS-
GRXQDGHQVLGDGPLQHUDOyVHD'02PD\RUTXHORV WLYRVRUDOHVHQPXMHUHVMyYHQHVHVSHTXHxRHOULHVJRDEVR-
SDFLHQWHVWUDWDGRVFRQEDMDVGRVLVGHHVWUyJHQRV\ORV luto por la píldora es de 3.6 por cada 10,000 mujeres por
SDFLHQWHVVLQWHUDSLDHVWURJpQLFDJFP2JFP2 DxRHOFXDOYDUtDFRQODSUHSDUDFLyQSULQFLSDOPHQWHSRUHO
\JFP2 respectivamente). El incremento anual de WLSRGHSURJHVWiJHQR8QDSUHSDUDFLyQTXHFRQWLHQHOHYRQ-
'02IXHVLJQLÀFDWLYDPHQWHPD\RUFXDQGRVHLQLFLDURQHV- RUJHVWUHORQRUHWLQGURQDStOGRUDGHVHJXQGDJHQHUDFLyQGD
WUyJHQRVDGRVLVGHDGXOWRVDQWHVGHORVDxRVDQWHV HOPHQRUULHVJRUHODWLYRGHWURPERVLV25\UHVSHFWL-
GHORVDxRVYVGHVSXpVGHORVDxRV vamente).
/RVDQWLFRQFHSWLYRVRUDOHVFRQGLIHUHQWHVSURJHVWiJHQRVGD
XQPD\RUULHVJRGHWURPERVLVJHVWRGHQR25OLQHVWUHQRO
25QRUJHVWLPDWR25GURVSLUHQRQD25DFH-
Anticonceptivos orales WDWRGHFLSURWHURQD25\GHVRJHVWUHO2528.
&XDQWRPiVVHDFHUFDHOSURJHVWiJHQRDODIyUPXODHV-
/RVDQWLFRQFHSWLYRVRUDOHVWLHQHQFRPRGHVYHQWDMDTXHQR WUXFWXUDOGHODSURJHVWHURQDSXUDFDUERQRV GLGURJHVWH-
KD\UHHPSOD]RGHHVWUyJHQRHQODVHPDQDGHGHVFDQVR(Q URQDPHGUR[LSURJHVWHURQDVHYHXQPHQRUHIHFWRHQOD
HVWDVHPDQDVXHOHSURGXFLUVHXQDKHPRUUDJLDSRUGHSULYD- JOXFRVD\HOPHWDEROLVPRGHORVOtSLGRV'HULYDGRVGHODWHV-
Documento descargado de http://www.elsevier.es el 20/06/2016. Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato.

128 )3pUH]%XHQRHWDO

WRVWHURQDFDUERQRV OLQHVWUHQROQRUHWLQGURQDWLHQHQ
XQHIHFWRDQDEyOLFRDQGURJpQLFRPD\RUHQFRPSDUDFLyQFRQ
ODSURJHVWHURQDSXUD29.
([LVWHODSRVLELOLGDGGHTXHHOXVRGHHWLQLOHVWUDGLROHQODV
GRVLVKDELWXDOPHQWHUHTXHULGDVSXHGDSURYRFDUKLSHUWHQ-
VLyQDUWHULDO\DTXHVXGHJUDGDFLyQOOHYDUtDDODSURGXFFLyQ
GHUDGLFDOHVOLEUHVTXHSRWHQFLDUtDQHODXPHQWRGHORVVXV-
tratos de renina circulantes.
Pacientes que presenten intolerancia a la lactosa son sus-
FHSWLEOHVGHVHUWUDWDGDVFRQYtDVDOWHUQDWLYDVDODRUDO\D
TXHXQFRPSULPLGRGHHVWUyJHQRV\RSURJHVWHURQDFRQWLH-
QHDOUHGHGRUGHPJGHODFWRVD.
(QSDFLHQWHVFRQ67KD\XQDXPHQWRGHORVQLYHOHVVpULFRV
GHHQ]LPDVKHSiWLFDV\ORVUHVXOWDGRVGHGLYHUVRVHVWXGLRV
VRQFRQWUDGLFWRULRVHQFRQWUDQGRHQDOJXQRVGHHVWRVHVWX-
GLRVTXHORVQLYHOHVHVWiQGLVPLQXLGRVSRUOD7+5(QXQHV-
WXGLRHQHOFXDOVHXWLOL]REHWDHVWUDGLROYtDRUDOOD
FDSDFLGDGKHSiWLFDGHFRQYHUVLyQGHJDODFWRVDLQGRFLDQLQD
YHUGH\DQWLSLULQDIXHURQQRUPDOHV\QRVHPRGLÀFDURQSRU
la THR30.
(OVHJXLPLHQWRLQGLFDGRGHODVSDFLHQWHVFRQVtQGURPHGH
7XUQHUHQ7+5VHPXHVWUDHQODWDEOD
Tabla 2 6HJXLPLHQWRGHODVSDFLHQWHVFRQVtQGURPHGH7XUQHU
Edad 6HJXLPLHQWRUHFRPHQGDGR
Todas las edades 3UHVLyQDUWHULDOFDGDDxR
(YDOXDFLyQFDUGLROyJLFDFDGDDxRV
2WRUULQRODULQJRORJtD\DXGLRORJtDFDGDDDxRV
(YDOXDFLyQRIWDOPROyJLFD
6HJXLPLHQWRSRUORVGLVWLQWRVHVSHFLDOLVWDVGHODVSDWRORJtDVGHWHFWDGDVHQDQWHULRUHVYLVLWDV
DxRV &RQWUROSRUHQGRFULQRORJtDLQIDQWLOGHYHORFLGDGGHFUHFLPLHQWR\IXQFLyQWLURLGHD
DxRV &DSDFLGDGGHVRFLDOL]DFLyQ
DxRV 3UXHEDGHIXQFLyQKHSiWLFD\WLURLGHDDQXDO
Conclusiones
(VLPSRUWDQWHLQGXFLU\PDQWHQHUHOGHVDUUROORSXEHUDO
FX\DDXVHQFLDJHQHUDXQVHULRLPSDFWRSVLFROyJLFRHQOD
DGROHVFHQWHFRQ676HYHHQIUHQWDGDDODIDOWDGHFDPELRV
ItVLFRVFDUDFWHUtVWLFRVDODDXVHQFLDGHPHQDUTXLD\PHQV-
WUXDFLRQHVTXHHQPXFKDVVRFLHGDGHVGHVGHXQSXQWRGH
YLVWDFXOWXUDOVHUtDHOSLODUVXIHPLQHLGDG
6HGHEHKDFHUSUHYHQFLyQGHHQIHUPHGDGHVFDUGLRYDVFX-
lares, reducción de la mortalidad por causa cardiovascular
FRPRODPHMRUDGHOSDWUyQGHOSHUÀOOLStGLFR
(ODERUGDMHGHODVSDFLHQWHVGHEHVHULQWHJUDOHLQFOXLU
KLVWRULDFOtQLFDFRPSOHWDH[DPHQItVLFRH[KDXVWLYRHVWX-
GLRVGHLPDJHQPHGLFLyQGHKRUPRQDV\FDULRWLSRFRQEDQ-
GHR*GHDOWDUHVROXFLyQ(QFLHUWDVSDFLHQWHVFRQVtQGURPH
GH7XUQHUH[LVWHQVLWXDFLRQHVHVSHFLDOHVHQODVTXHHVQHFH-
VDULRUHDOL]DUKLEULGDFLyQÁXRUHVFHQWHin situ para detectar
IUDJPHQWRVGHOFURPRVRPD<VLHVWHHVHOFDVRGHEHFRP-
SOHPHQWDUVHFRQUHVRQDQFLDPDJQpWLFDQXFOHDU\UHVHFFLyQ
GHHVWUtDJRQDGDOGHELGRDODOWRULHVJRGHJRQDGREODVWRPD5.
(VQHFHVDULRHOLPSXOVRGHLQYHVWLJDFLRQHVPiVDPSOLDV\
HVWDQGDUL]DGDVSDUDSRGHUOOHJDUDUHVXOWDGRVPiVFRQÀD-
3ODQWHDUWUDWDPLHQWRFRQKRUPRQDGHOFUHFLPLHQWR*+SRUHQGRFULQyORJRSHGLDWUD
3UHYHQFLyQ\RWUDWDPLHQWRGHREHVLGDG
'LÀFXOWDGGHDSUHQGL]DMHGpÀFLWGHDWHQFLyQ\FRQFHQWUDFLyQHVFRODU
0DORFOXVLyQGHQWDO\DQRPDOtDVGHFROXPQDYHUWHEUDOSULQFLSDOPHQWHHVFROLRVLV
DxRV 'HWHUPLQDFLyQGH/+\)6+SDUDYDORUDUIDOODRYiULFD
&RQVLGHUDUREWHQFLyQGH+RUPRQDDQWLPXOOHULDQDHLQKLELQD%
(YDOXDFLyQGHQWDO\GHRUWRGRQFLD
5D\RV;SDUDGHWHUPLQDFLyQGHHGDGyVHD
DxRV ,QLFLDUGRVLVEDMDVGHHVWUyJHQRVSUHIHUHQWHPHQWHYtDWUDQVGpUPLFD
(YDOXDFLyQGHOGHVDUUROORSXEHUDO
%~VTXHGDGHHQIHUPHGDGFHOLDFDFDGDDxRV
5HVRQDQFLDPDJQpWLFDGHWyUD[HQEXVFDGHGLODWDFLyQDyUWLFD
3UXHEDVGHIXQFLyQKHSiWLFDJOXFRVDHQD\XQROtSLGRVELRPHWUtDKHPiWLFDFUHDWLQLQDQLWUyJHQR
XUHLFRHQVDQJUH
6LJXLHQWHVDxRV ,QFUHPHQWRJUDGXDOGHGRVLVGHHVWUyJHQRV
DxRV $JUHJDUSURJHVWLQDV
,QLFLDUDYDORUDUIHUWLOLGDG\RDOWHUQDWLYDV
DxRV 'HQVLWRPHWUtDyVHD
&RQWLQXDUWHUDSLDGHUHHPSOD]RKRUPRQDO
DxRV 9DORUDUFRQWLQXDFLyQGHWHUDSLDGHUHHPSOD]RKRUPRQDOFRQpQIDVLVHQHOULHVJREHQHÀFLR
Documento descargado de http://www.elsevier.es el 20/06/2016. Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato.
5HHPSOD]RHVWURJpQLFRHQSDFLHQWHVFRQVtQGURPHGH7XUQHU
EOHV\TXHVHSXHGDQFRPSDUDUHQWUHVtFRQHOÀQGHUHDOL]DU
JXtDVSDUDHOPHMRUGLDJQyVWLFRPDQHMR\VHJXLPLHQWRGH
las pacientes con Síndrome de Turner.
7DPELpQHVLPSRUWDQWHXQDPD\RULQIRUPDFLyQVREUHHVWH
VtQGURPHDODSREODFLyQJHQHUDODILQGHLGHQWLILFDUPiV
WHPSUDQDPHQWHDODVSDFLHQWHVDIHFWDGDVRIUHFHUOHVXQ

15. 5RVV-/5RHOWJHQ'$QGURJHQUHVSRQVLYHDVSHFWVRIFRJQLWLRQ
LQ JLUOV ZLWK 7XUQHU V\QGURPH - &OLQ (QGRFULQRO 0HWDERO
1999;88:292-6.
16. 0HQHQGH]$/,QGXFFLyQDODSXEHUWDGHQHOVtQGURPHGH7XU-
QHU5HY&KLO3HGLDWU
 7RUUHV6DQWLDJR/0HULFT97DERDGD08QDQXH10HWDEROLF
WUDWDPLHQWRRSRUWXQRFUHDUJUXSRVGHDSR\RSDUDPHMRUDU
ODFDOLGDGGHYLGD\FRQFLHQWL]DUVREUHODLPSRUWDQFLDGH
FRQWLQXDUFRQODWHUDSLDKRUPRQDOGHUHHPSOD]RKDVWDLQL-
FLRVGHODWDGpFDGDGHODYLGD\DTXHPXFKDVSDFLHQWHVDO
GHMDUGHOOHYDUXQVHJXLPLHQWRFRQHOHQGRFULQyORJRSHGLD-
WUDDEDQGRQDQHOWUDWDPLHQWRSRUIDOWDGHLQIRUPDFLyQ\
HIIHFWVRIRUDOYHUVXVWUDQVGHUPDOEHWDHVWUDGLRO(DUDQ-
GRPL]HGFOLQLFDOWULDOLQJLUOVZLWK7XUQHUV\QGURPH-&OLQ(Q-
GRFULQRO0HWDE
18. 1DEKDQ=0'L0HJOLR/$4L5&RQMXJDWHGRUDOYHUVXVWUDQVGHU-
PDOHVWURJHQUHSODFHPHQWLQJLUOVZLWK7XUQHUV\QGURPHDSLORW
FRPSDUDWLYHVWXG\-&OLQ(QGRFULQRO0HWDE
19. &DQRQLFR02JHU(3OX%XUHDX*(VWURJHQDQG7KURPERHP-
orientación adecuada.
Bibliografía
1. %RQG\&1HZLVVXHVLQWKHGLDJQRVLVDQGPDQDJHPHQWRI7XUQHU
V\QGURPH5HY(QGRF0HWDE'LV
2. 0RUJDQ77XUQHU6\QGURPHGLDJQRVLVDQGPDQDJHPHQW$P)DP
3K\VLFLDQ
3. 'RPtQJXH]+7RUUHV0ÉOYDUH]+6tQGURPHGH7XUQHU([SH-
ULHQFLDFRQXQJUXSRVHOHFWRGHSREODFLyQPH[LFDQD%RO0HG
+RVS,QIDQW0H[
 *RQ]iOH]/)HOGPDQ67KHSDWLHQWZLWK7XUQHUV\QGURPHSX-
EHUW\ DQG PHGLFDO PDQDJHPHQW FRQFHUQV )HUWLO 6WHULO

5. 7LUR+HUQDQGH]'*XHUUHUR%XVWRV56tQGURPHGH7XUQHUFD-
ULRWLSR;<5HY0H[5HSURG
6. 0RUHQR(7UHVJXHUUDV+5HWUDVRVGHOFUHFLPLHQWRHG(VSD-
EROLVP5LVN(67+(56WXG\*URXS+RUPRQHWKHUDS\DQGYH-
QRXVWKURPERHPEROLVPDPRQJSRVWPHQRSDXVDOZRPHQ,PSDFW
RIWKHURXWHRIHVWURJHQDGPLQLVWUDWLRQDQGSURJHVWRJHQV7KH
(67+(56WXG\&LUFXODWLRQ
20. $QNDUEHUJ/LQGJUHQ&1RFWXUQDODSSOLFDWLRQRIWUDQVGHUPDO
HVWUDGLROSDWFKHVSURGXFHVOHYHOVRIHVWUDGLROWKDWPLPLFWKRVH
VHHQDWWKHRQVHWRIVSRQWDQHRXVSXEHUW\LQJLUOV-&OLQ(QGR-
FULQRO0HWDE
21. $QNDUEHUJ/LQGJUHQ&.ULVWURP%1RUMDYDDUD(3K\VLRORJLFDO
HVWURJHQUHSODFHPHQWWKHUDS\IRUSXEHUW\LQGXFWLRQLQJLUOV$
FOLQLFDO REVHUYDWLRQDO VWXG\ +RUP 5HV 3DHGLDWU 

22. /DEDUWD-0RUHQR0/ySH]-,QGLYLGXDOL]HGYVÀ[HGGRVHRI
RUDOEHWDRHVWUDGLROIRULQGXFWLRQRISXEHUW\LQJLUOVZLWK
7XUQHUV\QGURPHDQRSHQUDQGRPLVHGSDUDOOHOWULDO(XU-(Q-
GRFULQRO
23. /HWKDE\$+RUPRQHUHSODFHPHQWWKHUDS\LQSRVWPHQRSDXVDO
ZRPHQHQGRPHWULDOK\SHUSODVLDDQGLUUHJXODUEOHHGLQJ&R-
xD(GLFLRQHV'tD]6DQWRVS
 %DUUHGD%RQLV$&*RQ]iOH]&DVDGR,*UDFLD%RXWKHOLHU56tQ-
GURPH GH 7XUQHU$VRFLDFLyQ (VSDxROD GH 3HGLDWUtD 3URWRF
'LDJQ7HU3HGLDWU
8. GD6LOYD1%ROLQD(5*XLPDUmHV003XEHUWDOGHYHORSPHQW
SURÀOHLQSDWLHQWVZLWK7XUQHUVtQGURPH-3HGLDWU(QGRFULQRO
0HWDE
9. )ULDV-/'DYHQSRUW0/&RPPLWWHHRQ*HQHWLFVDQG6HFWLRQRQ
(QGRFULQRORJ\+HDOWVXSHUYLVLRQIRUFKLOGUHQZLWK7XUQHU6\Q-
GURPH3HGLDWULFV
10. /HSDJH-0D]DLND3.+RQJ'V5DPDQ05HLVV$O&RUWLFDO
EUDLQPRUSKRORJ\LQ<RXQJHVWURJHQQDLYHDQGDGROHVFHQW
HVWURJHQWUHDWHG JLUOV ZLWK7XUQHU V\QGURPH &HUHE &RUWH[
2013;23:2159-68.
11. 5RV&$ORLG,%DODVFK-7XUQHU·VVtQGURPHDQGRWKHUIRUPVRI
FRQJHQLWDO K\SRJRQDGLVP LPSDLU TXDOLW\ RI OLIH DQG VH[XDO
IXQFWLRQ$P-2EVWHW*\QHFRO
12. 0HQNH/$6DV7&(IÀFDF\DQGVDIHW\RIR[DQGURORQHLQJURZWK
KRUPRQHWUHDWHGJLUOVZLWK7XUQHUV\QGURPH-&OLQ(QGRULQRO
0HWDE
13. /DEDUWD-GH$UULED$0D\D\R(/RQJDV$$FWXDOL]DFLyQHQHO
FKUDQH'DWDEDVH6\VW5HY&'
 4XLJOH\&$:DQ;*DUJ6.RZDO.&XWOHU*%-U5RVV-/
(IIHFWVRIORZGRVHHVWURJHQUHSODFHPHQWGXULQJFKLOGKRRGRQ
SXEHUWDOGHYHORSPHQWDQGJRQDGRWURSLQFRQFHQWUDWLRQVLQSD-
WLHQWVZLWK7XUQHUVtQGURPH5HVXOWVRIDUDQGRPL]HGGRXEOp
EOLQGSODFHERFRQWUROOHGFOLQLFDOWULDO-&OLQ(QGRFULQRO0HWDE

25. .RGDPD0.RPXUD+.RGDPD71LKLR<.LPXUD7(VWURJHQ
WKHUDS\LQLWLDOLWHGDWDQHDUO\DJHLQFUHDVHVERQHPLQHUDOGHQ-
VLW\LQ7XUQHUV\QGURPHSDWLHQWV(QGRFU-
26. =DFKDULQ08VHRIDQGURJHQVDQGRHVWURJHQLQDGROHVFHQWHV²$
UHYLHZRIKRUPRQHUHSODFHPHQWWUHDWPHQW-3HGLDWU(QGRFUL-
QRO0HWDERO
 $KUHQGW+-%OHHGLQJSDWWHUQDQGF\FOHFRQWUROZLWKDQHVWUD-
GLROEDVHGRUDOFRQWUDFHSWLYHDVHYHQF\FOHUDQGRPL]HGFRP-
SDUDWLYHWULDORIHVWUDGLROYDOHUDWHGLHQRJHVWDQGHWKLQ\OHVWUD-
GLROOHYRQRUJHVWUHO&RQWUDFHSWLRQ
28. 9DQ+\OFNDPD$7KHYHQRXVWKURPERWLFULVNRIRUDOFRQWUDFHS-
WLYHVHIIHFWVRIHVWURJHQGRVHDQGSURJHVWRJHQW\SHUHVXOWVRI
WKH0(*$FDVHFRQWUROVWXG\%0-
29. 3LWNLQ-0DQDJHPHQWRISUHPDWXUHPHQRSDXVH0HQRSDXVH,QW
WUDWDPLHQWR\VHJXLPLHQWRGHOVtQGURPHGH7XUQHU67(VS(Q- 
GRFULQRO3HGLDWU 30. +¡MEMHUJ*+HQULN(2WW34XDQWLWDWLYHOLYHUIXQFWLRQVLQ7XU-
 :HQVLRH.0ROLQD55HYLVLyQGHODWHUDSLDKRUPRQDOGHUHHP- QHUVtQGURPHZLWKDQGZLWKRXWKRUPRQHUHSODFHPHQWWKHUDS\
SOD]RHQODDGROHVFHQWH5HY6RJLD (XU-(QGRFULQRO
Copyright of Perinatologia y Reproduccion Humana is the property of Instituto Nacional de
Perinatologia and its content may not be copied or emailed to multiple sites or posted to a
listserv without the copyright holder's express written permission. However, users may print,
download, or email articles for individual use.